In Brief:
This is the first reported case of accelerated retinal toxicity in the setting of hydroxychloroquine use for treatment of Sjögren syndrome with concomitant docetaxel and cyclophosphamide therapy for treatment of breast cancer reported in a 56-year-old white female patient.
